Supplementary Materials Supplemental Data supp_29_2_434__index. ameliorate DN. These findings may support the rationale for the clinical screening of peripherally restricted CB1R antagonists or the development of novel renal-specific GLUT2 inhibitors against DN. the facilitative transporter glucose transporter 2 (GLUT2) during order CX-5461 hyperglycemia may negatively impact renal function and the associated tubulointerstitial changes seen in… Continue reading Supplementary Materials Supplemental Data supp_29_2_434__index. ameliorate DN. These findings may support